Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer

BACKGROUND: Ventana ALK (D5F3) screening of anaplastic lymphoma kinase (ALK) gene rearrangement in tissue specimens has been approved by US FDA (Food and Drug Administration) to select treatment for non–small-cell lung carcinoma (NSCLC). However, tumor tissues are often not readily obtainable, and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hui Qin, Jia, Jia, Zhao, Lin Lin, Zhao, Huan, Wang, Cong, Sun, Yue, Ying, Jian Ming, Guo, Lei, Cao, Jian, Zhang, Zhi Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302402/
https://www.ncbi.nlm.nih.gov/pubmed/30572846
http://dx.doi.org/10.1186/s12885-018-5184-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302402/
https://www.ncbi.nlm.nih.gov/pubmed/30572846
http://dx.doi.org/10.1186/s12885-018-5184-x

Ejemplares similares